How macrophages manage cell drinking and inflammation

SHP1 Phosphatase/SYK Kinase Balance Controls the Actin Economy and Macropinocytosis in Macrophages

NIH-funded research South Dakota State University · NIH-11035188

This study is looking at how certain immune cells called macrophages take in and process materials from their surroundings, which is important for understanding and improving treatments for autoimmune diseases and inflammation.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionSouth Dakota State University NIH-funded
Lab location1 site (Brookings, United States)
Project IDNIH-11035188 on NIH RePORTER

What this research studies

This research investigates the mechanisms by which macrophages, a type of immune cell, regulate their ability to 'drink' and process materials from their environment, a process known as macropinocytosis. The study focuses on understanding the balance between two proteins, SHP1 phosphatase and SYK kinase, which play crucial roles in controlling the dynamics of actin, a protein that helps maintain cell structure and movement. By using advanced imaging techniques, researchers will observe how these proteins influence the efficiency of macropinocytosis in response to different inflammatory signals. The ultimate goal is to uncover new insights that could lead to better treatments for autoimmune diseases and inflammation-related conditions.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with autoimmune conditions or those experiencing chronic inflammation.

Not a fit: Patients with non-autoimmune related conditions or those not experiencing inflammation may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for managing autoimmune diseases and improving wound healing.

How similar studies have performed: Previous research has shown that understanding the molecular mechanisms of immune cell functions can lead to significant advancements in treatment strategies, indicating that this approach has potential for success.

Where this research is happening

Brookings, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Autoimmune Diseasesautoimmune disorderautoimmunity disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.